| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.03 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.03 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.04 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.33 | 0.04 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |